Full Text View
Tabular View
No Study Results Posted
Related Studies
Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody (PIANO)
This study is currently recruiting participants.
Verified September 2011 by NovImmune SA
Study NCT01430429   Information provided by NovImmune SA

First Received on September 5, 2011.   Last Updated on September 12, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Primary Biliary Cirrhosis
Additional conditions recognized in this trial
Fibrosis
Liver Cirrhosis
Liver Cirrhosis, Biliary
More general conditions related to this trial
Bile Duct Diseases
Biliary Tract Diseases
Cholestasis
Cholestasis, Intrahepatic
Digestive System Diseases
Liver Diseases
Pathologic Processes
Interventions listed in this trial
NI-0801
Additional drug interventions recognized in this trial
Antibodies, Monoclonal
Ursodeoxycholic Acid
More general drug interventions related to this trial
Cholagogues and Choleretics
Gastrointestinal Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
NovImmune SA


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services